Epiworld International Co., Ltd. (“EPIWORLD”) announced that its preliminary consolidated results for the year ended 31 December 2025 have been disclosed in Appendix III of the company’s prospectus dated 20 March 2026.
The filing, released on 31 March 2026 under Hong Kong Listing Rule 13.49(1), directs shareholders and potential investors to review the financial statements on the Hong Kong Stock Exchange website (www.hkexnews.hk) and the company website (http://www.epiworld.com.cn/).
The announcement was authorized by Chairperson and Executive Director Dr. Zhao Jianhui on behalf of the Board, which currently comprises three executive directors, three non-executive directors and three independent non-executive directors.
No additional operating or financial figures beyond those already included in the prospectus were provided in the announcement.
Comments